Difference between revisions of "Team:SYSU-MEDICINE"

Line 264: Line 264:
 
             margin-top: 100px;
 
             margin-top: 100px;
 
             z-index: 2000;
 
             z-index: 2000;
 +
        }
 +
        /*img content*/
 +
        .index-content .img-container{
 +
            width: 1070px;
 +
            margin: 0 auto;
 +
            background-image: url("https://static.igem.org/mediawiki/2016/6/64/T--SYSU-MEDICINE--home-home-body-img2.png");
 +
            background-repeat: no-repeat;
 +
            background-size: cover;
 +
            height: 1400px;
 +
        }
 +
        .index-content .img-container .my-icon{
 +
            position:relative;
 +
            width: 70px;
 +
            height: 70px;
 +
        }
 +
        .index-content .img-container .my-icon>img{
 +
            width: 100%;
 +
            height: 100%;
 
         }
 
         }
  
 +
        #icon-1{
 +
            left: 550px;
 +
            top: 100px;
 +
        }
 
     </style>
 
     </style>
 
     <script type="text/javascript">
 
     <script type="text/javascript">
Line 461: Line 483:
 
<div class="index-content">
 
<div class="index-content">
 
     <div class="img-container">
 
     <div class="img-container">
−
 
+
        <div class="my-icon" id="icon-1">
 +
            <img src="https://static.igem.org/mediawiki/2016/7/72/T--SYSU-MEDICINE--home-Button1.png">
 +
        </div>
 
     </div>
 
     </div>
 
</div>
 
</div>

Revision as of 15:58, 12 October 2016

MSCavalry

-----MSCs of
next generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of next generation is coming. SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.